5,7-DICHLOROKYNURENIC ACID SODIUM SALT
- CAS NO.:131123-76-7
- Empirical Formula: C10H5Cl2NO3
- Molecular Weight: 258.06
- MDL number: MFCD00083173
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-19 15:53:33
What is 5,7-DICHLOROKYNURENIC ACID SODIUM SALT?
The Uses of 5,7-DICHLOROKYNURENIC ACID SODIUM SALT
5,7-Dichlorokynurenic acid is a potent NMDA receptor glycine binding site antagonist.
What are the applications of Application
5,7-Dichlorokynurenic acid is a potent NMDA receptor glycine binding site antagonist
Definition
ChEBI: 5,7-dichloro-4-oxo-1H-quinoline-2-carboxylic acid is a member of quinolines.
Biological Activity
Potent antagonist at the glycine site of the NMDA receptor (K i = 79 nM vs. [ 3 H]-glycine).
storage
Room temperature
Properties of 5,7-DICHLOROKYNURENIC ACID SODIUM SALT
Boiling point: | 488.5±45.0 °C(Predicted) |
Density | 1.701±0.06 g/cm3(Predicted) |
storage temp. | Desiccate at RT |
solubility | 0.1 M NaOH: soluble |
form | solid |
pka | 3.30±0.40(Predicted) |
color | light yellow |
CAS DataBase Reference | 131123-76-7(CAS DataBase Reference) |
Safety information for 5,7-DICHLOROKYNURENIC ACID SODIUM SALT
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for 5,7-DICHLOROKYNURENIC ACID SODIUM SALT
New Products
4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium THOMAIND PAPER PH 2.0 TO 4.5 1 BOX BUFFER CAPSULE PH 9.2 - 10 CAP SODIUM CHLORIDE 0.1N CVS ALLOXAN MONOHYDRATE 98% PLATINUM 0.5% ON 3 MM ALUMINA PELLETS (TYPE 73) LITHIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
L-701,252
O-Phospho-L-serine
2-amino-4-phosphonobutyric acid
D-AP5
DL-2-AMINO-5-PHOSPHONOPENTANOIC ACID
Synthalin sulfate
(R)-CPP
Spermidine trihydrochloride
You may like
-
1-Methyl-6-oxo-1,6-dihydropyridazine-3-carbonitrile 98%View Details
99903-60-3 -
88491-46-7 98%View Details
88491-46-7 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
1784294-80-9 98%View Details
1784294-80-9 -
Lithium ClavulanateView Details
61177-44-4
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.